Dermata Therapeutics Stock Technical Analysis
| DRMA Stock | USD 1.24 0.02 1.64% |
As of the 13th of May 2026, Dermata Therapeutics is trading near 1.24 per share. Technical analytics identify Standard Deviation of 9.07, variance of 82.28, and Mean Deviation of 5.12. The analytical framework assesses directional consistency across time frames. Momentum and trend indicators are compared to peer averages and recent trading history.
Dermata Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Dermata, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to DermataDermata |
Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 4.0 | Buy | 1 | Odds |
Historical and current analyst recommendations for Dermata Therapeutics are aggregated from multiple sources. Comparing current recommendations to historical patterns provides additional analytical context. Sell-side analysts covering Dermata typically assign buy, hold, or sell ratings alongside 12-month price targets. Ratings are usually accompanied by a target price comparing Dermata's fair price to its market value.
Investors evaluate Dermata Therapeutics using market value and book value, each describing different facets of the business. Analytical frameworks help reconcile those views into a coherent picture.
It is useful to distinguish Dermata Therapeutics' value from its trading price, which are computed with different methods. For Dermata Therapeutics, key inputs include a P/B ratio of 0.81, and ROE of -0.12%.
What-If Analysis
What-if analysis for Dermata Therapeutics is essentially a historical sensitivity test that shows how changes in the investment horizon could have altered realized return, drawdown, and timing outcomes. The point is not to predict the future from one chart, but to understand how sensitive the trade has been to timing and holding assumptions.
| 02/12/2026 |
| 05/13/2026 |
Placing 0.00 into Dermata Therapeutics on February 12, 2026 with a hold through today would gain 0.00 in total return. In total, that is a 0.0% return on investment in Dermata Therapeutics in total across 90 days. Dermata Therapeutics has comparable peers such as Avenue Therapeutics, Psyence Biomedical, Virax Biolabs, Elevai Labs, GT Biopharma, Revelation Biosciences, and Artelo Biosciences. Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializ... More
Upside and Downside Indicators for Dermata Therapeutics Summary
The momentum profile for Dermata Therapeutics describes how price movement distributes across upside and downside channels. Momentum distribution across the range reveals whether the current trend is accelerating or fading.
| Information Ratio | -0.02 | |||
| Maximum Drawdown | 80.83 | |||
| Value At Risk | -11.83 | |||
| Potential Upside | 7.53 |
Market Risk Indicators for Dermata Therapeutics Snapshot
The risk context for Dermata Therapeutics is expressed through volatility and drawdown-related metrics. Drawdown depth and frequency distinguish between volatile-but-recoverable and structurally declining price behavior.| Risk Adjusted Performance | -0.01 | |||
| Jensen Alpha | -0.22 | |||
| Total Risk Alpha | -0.06 | |||
| Treynor Ratio | -0.55 |
Mean reversion in Dermata Therapeutics' price occurs when temporary dislocations correct back toward its historical intrinsic value estimate. This tendency of Dermata Therapeutics' price to converge to an average value over time is called mean reversion.
Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | -0.01 | |||
| Market Risk Adjusted Performance | -0.54 | |||
| Mean Deviation | 5.12 | |||
| Coefficient Of Variation | -4,216 | |||
| Standard Deviation | 9.07 | |||
| Variance | 82.28 | |||
| Information Ratio | -0.02 | |||
| Jensen Alpha | -0.22 | |||
| Total Risk Alpha | -0.06 | |||
| Treynor Ratio | -0.55 | |||
| Maximum Drawdown | 80.83 | |||
| Value At Risk | -11.83 | |||
| Potential Upside | 7.53 | |||
| Skewness | 2.35 | |||
| Kurtosis | 16.44 |
Dermata Therapeutics Backtested Returns
Dermata Therapeutics continues to exhibit an extremely high risk exposure over the designated horizon. It has a Sharpe Ratio of 0.0252, evidencing risk-calibrated returns. We identified twenty-three technical indicators influencing the company's volatility profile. Please examine metrics such as standard deviation of 9.07, variance of 82.28, and mean deviation of 5.12 to validate volatility assumptions. On a scale of 0 to 100, Dermata Therapeutics holds a performance score of 2. The company has a market beta of 0.41, which conveys generally lower market sensitivity than the broad market. Dermata Therapeutics moves in the same direction as the market but with less intensity, offering a degree of cushion during selloffs.
Auto-correlation | 0.05 |
Virtually no predictability
Serial correlation analysis for Dermata Therapeutics reveals virtually no predictability across the intervals from 12th of February 2026 to 29th of March 2026 and from 29th of March 2026 to 13th of May 2026. The degree of alignment between past and current intervals shapes expectations about Dermata Therapeutics's price persistence. At 0.05, only as little as 5.0% of current Dermata Therapeutics price movement aligns with historical price trajectory.
| Correlation Coefficient | 0.05 | |
| Spearman Rank Test | -0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Dermata Therapeutics technical stock analysis focuses on price and volume behavior. Common inputs include moving averages, RSI, and price-based signals.
Technical Analysis
This analysis covers thirty-seven data points across the selected time horizon. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Dermata Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Technical Analysis Methodology & Indicators
Technical analysis of Dermata Therapeutics evaluates price structure, momentum, and volatility clustering. Price movements may be comparatively less responsive to macroeconomic volatility. Dermata Therapeutics has a market cap of 4.91 million, ROE of -1.94%.
Reported values for Dermata Therapeutics are derived from periodic company reporting and market reference feeds and standardized for analysis.
Editorial review and methodology oversight provided by: Rifka Kats, Member of Macroaxis Editorial Board
Technical Indicators
A technical review of Dermata Therapeutics can improve timing discipline by comparing momentum, reversal risk, and confirmation signals across several time horizons. A disciplined technical workflow separates stronger setups from noisier price action.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | -0.01 | |||
| Market Risk Adjusted Performance | -0.54 | |||
| Mean Deviation | 5.12 | |||
| Coefficient Of Variation | -4,216 | |||
| Standard Deviation | 9.07 | |||
| Variance | 82.28 | |||
| Information Ratio | -0.02 | |||
| Jensen Alpha | -0.22 | |||
| Total Risk Alpha | -0.06 | |||
| Treynor Ratio | -0.55 | |||
| Maximum Drawdown | 80.83 | |||
| Value At Risk | -11.83 | |||
| Potential Upside | 7.53 | |||
| Skewness | 2.35 | |||
| Kurtosis | 16.44 |
May 13, 2026 Daily Trend Indicators
A technical review of Dermata Therapeutics can improve timing discipline by comparing momentum, reversal risk, and confirmation signals across several time horizons. A disciplined technical workflow separates stronger setups from noisier price action.
| Accumulation Distribution | 2,431 | ||
| Daily Balance Of Power | 0.40 | ||
| Rate Of Daily Change | 1.02 | ||
| Day Median Price | 1.23 | ||
| Day Typical Price | 1.23 | ||
| Price Action Indicator | 0.03 |
Popular Tools for Dermata Stock analysis
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capitalStock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websitesETFsFind actively traded Exchange Traded Funds (ETF) from around the worldPortfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization enginePattern RecognitionUse different Pattern Recognition models to identify potential trend changes across multiple global exchangesCorrelation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated